For women with moderate-to-severe vasomotor symptoms associated with endocrine therapy for hormone receptor (HR)-positive breast cancer, elinzanetant, a neurokinin-targeted therapy, reduces the frequency of vasomotor symptoms, according to a study published online June 2 in […]
A study conducted by researchers at the Center for Cell-Based Therapy (CTC) highlights key proteins and signaling pathways involved in the efficacy of immunotherapy based on CAR-T cells (lymphocytes modified in the laboratory to fight […]
For decades, gynecologic cancer treatment has used aggressive surgical intervention and chemotherapy. These methods often harmed fertility. They also caused severe side effects and an uncertain prognosis.This article was originally published on MedicalXpress.com
After FDA approval in late 2023, the non-invasive liver tumor treatment histotripsy has been used at University of Michigan Health since early 2024.This article was originally published on MedicalXpress.com
Researchers have been working toward using the gut microbiome as a clinical target for screening for colorectal cancer. This would ideally allow simple stool tests to be used for early detection of the disease in […]
A study led by Cancer Center at Illinois (CCIL) member Jason Ridlon, associate professor of animal sciences in the College of Agricultural, Consumer and Environmental Sciences (ACES), has revealed that bacteria in the urinary tract […]
Scientists at UC San Francisco have discovered how pancreatic cancer cells thrive in the lungs or liver, environments that are as distinct to cells as the ocean and desert are to animals. The spread of […]
Starting breast cancer screening in women’s early 40s will save more lives, a new study argues.This article was originally published on MedicalXpress.com
Most of the cells in our bodies don’t move—they stay where they’re supposed to in service to our organs and biological systems. But aggressive cancer cells behave differently, spreading and ultimately damaging the tissues they […]
The Experimental Drug Development Center (EDDC), Singapore’s national platform for drug discovery and development, has announced the presentation of updated clinical data for the ongoing Phase I trial for EBC-129 at the 2025 Annual Meeting […]
© 2025 SimplyWell.ca